Crossover Trial of Mazindol for Cocaine Dependence
- 1 April 1993
- journal article
- Published by Wiley in The American Journal on Addictions
- Vol. 2 (2) , 161-164
- https://doi.org/10.1111/j.1521-0391.1993.tb00216.x
Abstract
Mazindol, an indirect dopamine agonist, was given at 2 mg qd to 19 cocaine‐dependent, methadone‐maintained patients during a 2‐week, placebo‐controlled, crossover trial. Patients showed no significant reduction in cocaine use, but they had increased cocaine craving on mazindol compared with placebo.Keywords
This publication has 16 references indexed in Scilit:
- Pharmacotherapy for Cocaine-Abusing Methadone-Maintained Patients Using Amantadine or DesipramineArchives of General Psychiatry, 1992
- Bupropion Reduces Cocaine Abuse in Methadone-Maintained PatientsArchives of General Psychiatry, 1991
- Pharmacotherapeutic Interventions for Cocaine Abuse Matching Patients to TreatmentsJournal of Nervous & Mental Disease, 1989
- TREATMENT OF COCAINE ABUSE WITH MAZINDOLThe Lancet, 1989
- Cocaine and Other StimulantsNew England Journal of Medicine, 1988
- Cocaine Receptors on Dopamine Transporters Are Related to Self-Administration of CocaineScience, 1987
- Single-dose bromocriptine reverses cocaine cravingPsychiatry Research, 1987
- Amphetamine, mazindol, and fencamfamin in narcolepsy.BMJ, 1985
- Methylphenidate Treatment of Cocaine Abusers without Attention Deficit Disorder: A Negative ReportThe American Journal of Drug and Alcohol Abuse, 1985
- Mazindol in the Treatment of Parkinson's DiseaseArchives of Neurology, 1983